NFG
SGMO

Nations Financial Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Nations Financial Group’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-23,386
Closed -$23.9K – 696
2024
Q4 		$23.9K Hold
23,386
– – ﹤0.01% 664
2024
Q3 		$20.3K Buy
23,386
+9,136
+64% +$6.69K ﹤0.01% 668
2024
Q2 		$5.11K Hold
14,250
– – ﹤0.01% 629
2024
Q1 		$9.55K Sell
14,250
-402
-3% -$292 ﹤0.01% 620
2023
Q4 		$7.96K Buy
14,652
+3,010
+26% +$1.39K ﹤0.01% 618
2023
Q3 		$6.98K Hold
11,642
– – ﹤0.01% 612
2023
Q2 		$15.1K Buy
11,642
+200
+2% +$273 ﹤0.01% 611
2023
Q1 		$20.1K Buy
+11,442
New +$32.7K ﹤0.01% 612

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nations Financial Group's SGMO Position: Q1 2025 in Review

Nations Financial Group sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2025, closing a stake of 23,386 shares — an estimated $23.9K sold.

Nations Financial Group first reported a position in SGMO in Q1 2023 and held it in 8 quarters. The position peaked at $23.9K in Q4 2024. 122 funds tracked by Wall St. Rank hold SGMO as of Q1 2025.

  • Nations Financial Group reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2025 after selling out during the quarter.
  • Nations Financial Group sold 23,386 SANGAMO THERAPEUTICS INC shares in Q1 2025, an estimated $23.9K.
  • Nations Financial Group first reported a position in SANGAMO THERAPEUTICS INC in Q1 2023 and held it in 8 quarters.
  • Nations Financial Group's SANGAMO THERAPEUTICS INC position peaked at $23.9K in Q4 2024.
  • 122 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2025.

Based on Nations Financial Group's 13F filing for Q1 2025, filed 13 May 2025.